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ABSTRACT 
Background: The story of HIV in South Africa has been riddled with confusion and 
misinformation, claiming the lives of countless people.  In 2014 HIV claimed the lives of over 
140,000 people across the country. While the last 10 years have seen immense growth and 
improvement with regards to access to antiretroviral therapies (ART), new gaps in coverage have 
become apparent. We have entered an era in which children born HIV-positive are able to access 
treatment, and are likely to live through their teen years and beyond, but it is during this 
adolescent period that unique barriers threaten ART adherence efforts. Objective: This paper has 
two aims. Aim 1: Conduct a literature review of peer reviewed publications addressing barriers 
to ART adherence among HIV-positive adolescents in South Africa. Aim 2: Propose a pilot 
research project to improve ART adherence among adolescents seeking treatment in Khayelitsha, 
South Africa. Conclusion: There remains a notable gap in the literature with regards to data that 
determines and analyzes the barriers that HIV-positive adolescents on ART face within the 
context of South Africa. This paper seeks to fill the identified gaps and aims to summarize the 
important themes resulting from the literature search. In addition, it highlights potential barriers 
to adherence and outlines a pilot program to identify and address barriers for HIV-positive 
adolescents in Khayelitsha. Public Health Relevance: According to UNAIDS, if we address the 
issues of ART adherence within the adolescent population the current HIV/AIDS climate will 
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change for the better. Increased adherence leads to lower and undetectable viral loads; lower 
viral loads then leads to a decreased likelihood of transmission, both horizontally and vertically. 
Ultimately, if greater adherence were to be achieved, there would be fewer people living with 
HIV and more people enabled to live longer, healthier and more productive lives. 
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1.0  INTRODUCTION 
The summer of 2015 I conducted my practicum with Doctors Without Borders (MSF) in 
Khayelitsha, a township outside of Cape Town, South Africa. I worked closely with MSF’s 
pediatric doctors and nurses and observed as many of their HIV-positive patients experienced 
virological failure due to antiretroviral treatment failure. After speaking with the clinic staff, it 
became apparent that they were relatively successful in managing the majority of their cases, but 
faced many problems with their adolescent patient population. The adolescent patients presented 
unique challenges with disease and medication management, and the staff was often unsure how 
to best address the issues at hand.   
 My experience with MSF refined the approach I took regarding my thesis. I knew 
anecdotally that adolescent patients were facing unique barriers to ART adherence, but I wanted 
to know what barriers the literature explicitly identified. Although the literature did identify 
important themes and concepts related to the topic of interest, to my chagrin, it lacked data 
identifying specific barriers that inhibit adherence for HIV-positive adolescents in South Africa. 
Considering the minimal literature uncovered from the search, I decided to take an 
unconventional approach towards this thesis and create a document with two overarching aims. 
Aim 1: Conduct a literature review of peer reviewed publications addressing barriers to ART 
adherence among HIV-positive adolescents in South Africa. Aim 2: Propose a pilot research 
2 
project to improve ART adherence among adolescents seeking treatment in Khayelitsha, South 
Africa. 
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2.0  BACKGROUND 
2.1 SCOPE OF THE PROBLEM 
There are currently 35 million people in the world living with HIV/AIDS.  Since the beginning 
of the global HIV/AIDS epidemic there have been 39 million deaths attributed to HIV-related 
causes [1]. The global HIV prevalence in adults is 0.8%, 71% of which are people living in Sub-
Saharan Africa [1], and only half of whom know their HIV-positive status [2]. In South Africa 
the national HIV prevalence rate is 18.8% [3]—totaling to 6.3 million people currently living 
with HIV/AIDs [2]—the most of any country in Sub-Saharan Africa. Within South Africa, the 
national prevalence rate for people aged 15-24 is 7.1% [3]. As identified in South Africa’s 
National Strategic Plan on HIV, STIs and TB for 2012-2016, populations at high risk for 
acquiring HIV include: young women between the ages of 15-24, people living in informal 
settlements, young people not attending school, people of low socio-economic status, 
uncircumcised men, people using illegal drugs, people who frequently abuse alcohol, transgender 
persons, orphans and other vulnerable children and youth [4]. 
Antiretroviral therapy (ART) (also known as highly active antiretroviral therapy 
[HAART]) is a key component to curbing the spread of HIV. When adequately adhered to, ART 
is known to stop the progression of the virus and allow for the HIV-infected person to live a 
longer, more productive life [5]. The therapy is generally a regimen of at least three antiretroviral 
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(ARV) drugs [5]. There are more than 25 ARVs that fall into six different categories: 
nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse 
transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), a fusion inhibitor (FI), a CCR5 
antagonist, and integrase strand transfer inhibitors (INSTIs). 
2.2 HISTORY OF HIV AND ART IN SOUTH AFRICA 
The first two diagnosed cases of AIDS in South Africa occurred December 1982 [6], in two 
homosexual flight stewards in their early 40s [7]. The men acquired the virus while traveling to 
the United States—both cases progressed rapidly and the men died shortly after their return to 
South Africa [7]. Throughout the 1980s the majority of AIDS diagnoses in South Africa were 
limited to gay men and blood transfusion recipients. Until the late 1980s, the rate of the virus 
present in the heterosexual population remained relatively low with only 12 cases identified in 
the city of Pretoria in 1986 [8, 9].  Even as the virus spread beyond the initially limited 
population the issue went largely unaddressed by the South African Apartheid government as 
AIDS was seen to be an issue only within black and gay communities [9].  
In 1990 the government began to measure infection rates by collecting data from 
anonymous antenatal surveys.  The results showed a volatile and rapid increase, suggesting that 
the national prevalence rate was 0.76%, which increased to 10.44% by 1995, and astonishingly 
to 22.4% by 2000 [9, 10]. Despite the rapidly increasing prevalence rates, the government denied 
the evidence and made no concerted efforts to address the issue [11]. Despite what the global and 
scientific community repeatedly suggested about the spread and management of the disease, 
South African government officials were often found reporting the opposite. For example, in 
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1999, President Thabo Mbeki defended a statement that HIV does not cause AIDS and any 
medications created to manage HIV were unnecessary [12]. He also claimed that Zidovudine, a 
proven effective drug used to prevent the transmission of HIV from mother to child in utero, had 
“toxic” side effects and was a “danger to health” [12]. As a continuation of these claims the 
government restricted the use of Nevirapine, a medication in the antiretroviral family, although it 
had been donated to the South African Government by the global community [11]. The 
government instituted ban on life-saving medication was ultimately seen as unconstitutional and 
was overturned by the High Court in July of 2002, enabling HIV-positive pregnant women to 
access prevention of mother to child transmission (PMTCT) services and medications [11, 13, 
14].  
The first ART regimen was approved by the United States Food and Drug Administration 
(FDA) by the end of 1995 and made available to the American public shortly thereafter [15, 16]. 
In contrast, widespread implementation of ART programs in South Africa did not occur until 
April 1st, 2004 [11], all while PMTCT programs and ARV campaigns were well underway in 
neighboring country, Botswana, by 1999 and 2001, respectively. Chigwedere et al. [17] 
conducted a study in efforts to estimate the benefits lost due to South Africa’s delay in 
implementing widespread ART programs. The results suggested that more than 330,000 lives 
(approximately 2.2 million person-years) were lost due to the lack of ART implementation.  
Despite the complicated history in South Africa in the fight against HIV, the past five 
years have been largely defined by growth and success. With the election of President Jacob 
Zuma in 2009 and the appointment of Dr. Aaron Motsoaledi as South Africa’s Minister of 
Health, new attention and urgency was given to the HIV situation in South Africa [11]. After Dr. 
Motsoaledi acknowledged that the past 10 years were spent “pedaling backwards”, the president 
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declared World AIDS Day 2009 as, “the day on which we start to turn the tide in the battle 
against AIDS” [11, 18]. The effects of this new charge were seen shortly thereafter; the rate of 
adults on ART rapidly increased from 4.9% in 2004 to 55% in 2010 [11, 19]. Simultaneously, 
with the increase of coverage and continual monitoring, segments of the population that did not 
have adequate access to care have been identified. On World AIDS Day 2011, South Africa 
released their third National Strategic Plan (NSP) for the years 2012 – 2016 which included a 
new and emphasized focus on under-reached populations such as sex workers, men who have 
sex with men, and adolescents [4, 11].  
2.3 ART AND TREATMENT FAILURE 
Antiretroviral treatment failure is defined as an HIV-positive patient who is experiencing 
virological failure, which can occur due to poor medication adherence, drug resistance, poor 
medication absorption, inadequate dosing, and drug interactions [20]. A person’s virological 
state is measured through a viral load blood test. If the results shows that a person’s blood 
contains anywhere from 1,000 to 5,000 copies of the HIV virus per milliliter, they are said to be 
experiencing virologic failure [21]. High adherence, defined as taking the prescribed medication 
95% or more of the time, is necessary for a greater chance of virological suppression; a state 
when the virus is controlled within an individual’s system [22]. If a person is able to achieve 
longstanding suppression, their immune system can restore functionality and will likely avoid the 
progression of HIV to AIDS [23, 24].  
Based on the National Institute of Health’s AIDS info [25], there are three stages of HIV 
infection: 1) acute infection 2) chronic infection and 3) AIDS.  Acute infection, the earliest stage, 
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is when the virus multiplies rapidly and destroys the immune system’s CD4 cells. The chronic 
infection stage is asymptomatic and is when the virus continues to multiply in the body, although 
at a much slower rate than in the acute phase. Without regular treatment, the virus usually 
advances to the AIDS stage in 10 to 12 years. AIDS is diagnosed when a person has a CD4 count 
of less than 200 cells/cubic millimeter and/or they have one or more opportunistic infections (i.e. 
pneumonia, tuberculosis). Without treatment, a person with AIDS will generally live three years 
following their diagnosis. 
2.4 TREATMENT FAILURE IN ADOLESCENTS 
Adherence to an ART regimen is key if an HIV-positive individual is to live a long, productive 
life. Adherence issues are, however, present in both adult and adolescent populations. A 
combination of factors, including but not limited to, the relationships between the patient and the 
provider, medication issues, psychological status, and structural issues can impede adherence 
efforts [26]. Adolescents face a unique set of challenges with ART and management. In a paper 
reviewing the literature to identify ART management challenges for perinatally HIV-infected 
adolescents, authors Agwu and Fairlie [26] identified barriers including: diverse presentation of 
HIV and its symptoms, ART usage in a setting of rapid physical growth and development, 
nonadherence, resistance, long-term treatment management, and difficult transition from 
pediatric care to adult care.  
Adolescents, according to the World Health Organization [27], are young people between 
the ages of 10 and 19 years. It is reported that in both high and low income countries, adolescents 
have a lower rate of ART adherence than HIV-positive adults [28-31]. Many HIV-positive 
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perinatally infected adolescents display an array of delays, including delayed onset of puberty 
[32], decreased levels of school functioning [33, 34] and behavioral problems [35]. Additionally, 
many HIV-positive adolescents face family disruptions, often including loss of a parent or 
primary caregiver [36]. These challenges can hinder an HIV-positive adolescent's ability to 
properly adhere to an ART regimen.  
Pediatric and adolescent treatment failure is often a neglected and under-recognized issue 
within the realm of HIV treatment [37], possibly because adolescents face such unique 
circumstances when compared to their pediatric and adult counterparts [26]. This lack of 
recognition poses a severe threat given that 2.1 million adolescents are HIV-positive worldwide 
[38]. According to the UNAIDS 2014 report on HIV prevention, treatment, care and support for 
adolescents and youth, it is critically important to address the issues surrounding adolescent and 
youth HIV because this group has the, “opportunity to end the AIDS epidemic through 
leadership and behavioral and social changes which would have an impact on new HIV 
infections, AIDS-related deaths and the way the world responds to HIV and AIDS” [39]. 
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3.0  LITERATURE SEARCH 
In efforts to assess the barriers to ART adherence that adolescents face specifically in South 
Africa, a search of the current literature was conducted. 
3.1 METHODS 
3.1.1 Search Strategy 
Under the guidance of a Health Systems Librarian at the University of Pittsburgh, I created a 
search strategy to best extract relevant articles on the topic of interest. The terms used to create 
this search were variations of the following: antiretroviral therapy, medication adherence, 
HIV/AIDS, adolescents and South Africa (See Appendix A). The initial PubMed search resulted 
in 120 articles, with none excluded based on date or language.  This PubMed search was adjusted 
for both PsycINFO and Global Health databases, which resulted in an additional 87 articles. 
After removing the duplicate articles, the result was 192 unique articles.  
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3.1.2 Data Extraction and Management 
The title and abstracts were extracted from each of the 192 articles. Two independent reviewers 
read the title and abstracts for each article and decided to keep or pass the article based on 
established inclusion and exclusion criteria. For an article to be included in the analysis it had to 
include the following topics: 
Population 
of Interest: 
Adolescents; including any papers that have 
a target population within the specified 10-19 
age range. Include any papers that deal with 
pediatrics but do not specify age. 
Location: South Africa 
Condition: HIV/AIDS 
Medication: Antiretroviral Therapy 
Behavioral 
Component: Medication Adherence 
Specified Date: Include publications from all dates1 
Figure 1. Inclusion/Exclusion Criteria 
1 Oldest article dates back to 2003. Based on complex history of ART in South Africa, decided to not 
initially exclude.  
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The reviewers were not blinded to the names of the authors or journals. Following the initial 
independent sorting, the reviewers agreed to include nine of the papers, exclude 163, and due to 
disagreeing results, discuss 20. The discussion included an in depth look at the title and abstract 
to determine if the paper met the inclusion criteria. Following the discussion, the reviewers 
decided to include nine of the 20 papers that were initially disagreed upon, resulting in a total of 
18 papers that were read and analyzed for potential barriers to adherence.  
 
Figure 2. Literature Review Flow Chart 
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Both readers read the articles independently and extracted corresponding information regarding 
adolescent ART adherence (see Appendix B). Following the inclusion criteria guidelines two 
articles remained that directly measured adherence in HIV-positive adolescents in South Africa. 
Five others were identified as not directly measuring adherence as an outcome variable, but still 
discussed important themes surrounding HIV-positive adolescents in care in South Africa, and 
were therefore kept. Because of the relatively small number of articles that met the inclusion 
criteria (n=2), I conducted a thematic review of all the relevant articles.  
Theme Identified Paper Cited (n=6) 
Clinic Experiences Hornschuh et al. (2014) Pienaar and Visser (2012) 
Mental Health Petersen et al. (2010) Li et al. (2010) 
Social Support 
Bhana et al. (2014) 
Snyder et al. (2014) 
Pienaar and Visser (2012) 
Hornschuh et al. (2014) 
Figure 3. Thematic Review 
The themes were identified and extracted by one reader and are discussed in the results section. 
Themes were chosen for thematic review if they were identified in two or more papers. The 
results section outlines the findings from the thematic review (n=6) and the literature 
review (n=2). The thematic review includes one article from the literature review, as it 
contained important themes relevant to the results.  Additionally, the literature review 
summarizes the findings from the two articles extracted from the literature search that 
directly measure adherence. The discussion section gives context as to other studies that 
identify these themes as potential compounding variables that can directly or indirectly effect 
adherence to antiretroviral therapy.  
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3.2 RESULTS 
3.2.1 Thematic Review 
3.2.1.1 Clinic Experiences  
The literature search resulted in two papers that discuss the importance of the clinic experience 
to HIV-positive adolescent patients. One study, conducted by Hornschuh et al. [40], examined 
in-clinic experiences of 18 HIV-positive young adults (aged 15 to 25 years old) in Soweto, a 
township community in Johannesburg. According to respondents, it was very important that the 
providers demonstrate nonjudgmental attitudes and ensure complete confidentiality. When staff 
embodied these characteristics, patients felt most at ease and trusted the care being provided. 
Patients expressed that when nurses treated them as individuals and with respect, they were more 
likely to see the nurses as “friends” or “mothers”.  They were also more likely to speak candidly 
and discuss difficult topics with them.  In fact, participants admitted they would rather talk to a 
clinic worker instead of their own mother about sensitive topics such as sex, condom use, 
romantic relationships, medication difficulties, and drug abuse. Familiarity and consistency with 
the clinic staff was important to patients, as patients wanted the staff to know them on an 
individual level. Patients expressed concern with the thought of having to transfer clinics due to 
the phasing out process from a pediatric clinic and into an adult clinic.  They fear this transition 
may jeopardize confidentiality, that they may feel stigmatized, and that medication availability 
may be less consistent.  
A study conducted by Pienaar and Visser [41] examined the disease-management efforts 
of six HIV-positive adolescents (aged 12-18 years) in Pretoria. The respondents from this study 
identified lack of communication and impersonal interactions with providers as the most 
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prominent barriers to proper disease management [41]. The findings from these two papers 
suggest that experiences within the clinic do affect adolescents’ perception of care. 
3.2.1.2 Mental Health 
Petersen et al. [42] conducted a qualitative investigation to examine the psychosocial challenges 
and protective influences for coping among 25 HIV-positive adolescents in Durban. The major 
psychosocial challenges found were: dealing with the loss of one or both parents, embracing 
their HIV status, perceived and felt stigma, and disclosure issues. The coping factors identified 
were: the availability of HIV information, the ability to create goals and dreams for the future, as 
well has having positive family and peer support. All of these factors play a role in emotional 
and mental well-being of the adolescent. 
Li et al. [43] conducted four focus groups with 26 total participants (10 – 15 years) to 
identify the needs of adolescents on ART in Cape Town. Results from this study suggest that 
participants embrace both positive and negative outlooks on life. Respondents stated that HIV is 
painful, both physically and emotionally—their status causes them to feel fearful, angry, and 
causes some of them to contemplate suicide. Being HIV-positive was found to drive participants 
to isolate themselves and retract from friends and activities they enjoy. This isolation is due to 
fear and potential stigma that could occur if their status were made known to friends and 
community members. Conversely, adolescents were able to maintain a positive mindset when 
they reported having strong support from their family and friends. 
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3.2.1.3 Social Support 
Family/Caregiver Support 
Bhana et al. [36] evaluated the VUKA Family Program—a pilot program that used a family-
based psychosocial intervention in KwaZulu-Natal. In this evaluation, 33 patients (10-14 years) 
received the intervention and were compared with a control group. The results suggest that 
certain aspects of familial and peer support may improve ART adherence in adolescents. The 
VUKA Family Program not only created a support group for adolescent patients, but also created 
a system for parents and caregivers to learn how to best help their child, resulting in improved 
caregiver-child support. With improved support, adolescents were seen to have higher rates of 
adherence. And while many of the adolescents claimed primary responsibility for taking their 
medication, caregivers began to provide much-needed backup assistance. 
 
Peer Support 
The Hlanganani Program, a support group for recently diagnosed 16-24 year olds in Cape Town 
(n=109), was evaluated by Snyder et al. [44]. Results show that participants were initially 
unaware of how to access support and different services from their community, especially given 
the fear of stigma. Following the three-session support group, participants exchanged cell phone 
numbers with one another and expressed interest in more group sessions. Following the 
completion of the program, both rates of disclosure and self-reported feelings of support 
improved for the participating adolescents. The program helped increase participants self-
efficacy in accessing their surrounding social network and support systems. With increased 
access of said network, rates of perceived support increased.  
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Clinician Support 
As previously mentioned, from the Pienaar and Visser paper [41], the experiences that 
adolescents have in health care facilities and with health care workers do affect them and have 
the potential to affect their efforts regarding disease management. Aside from traditional 
functions, the clinic also serves to provide a social network for many HIV-positive adolescents. 
As Hornschuh et al. [45] reported, when good interactions occur in the clinic setting, adolescents 
are much more likely to trust the clinic workers and heed their instruction. The increase of 
positive interactions aids in creating a strong network for adolescents within the clinic setting 
and decreases the likelihood of loss to follow-up. 
3.2.2 Literature Review Results 
3.2.2.1 The VUKA Family Program [36] 
The aforementioned Bhana et al. paper [36] evaluated The VUKA Family Program to determine 
the effect that a family-based psychosocial intervention can have on HIV-positive adolescents 
with regards to adherence, mental health, self-concept, HIV knowledge, treatment knowledge, 
youth-caregiver communication and perceived stigma. The program used evidence based 
interventions (CHAMP and CHAMP+) [42] to target HIV-positive adolescents (10-14 years) in 
KwaZulu-Natal. The VUKA intervention was delivered to 65 adolescents through 10 sessions 
that lasted over a three-month period. Sessions were conducted by community lay-counselors 
and utilized a culturally-adapted cartoon story line within the support-group setting.  
Adherence was measured using a derivative from the Pediatric AIDS Clinical Trials 
Group [46, 47], on a single item scale, and by qualitative process evaluation measures. 
Comparing participants enrolled in the VUKA group to the control group, the adolescents in the 
17 
program showed significant improvements in self-reported ART adherence. Looking at self-
reported adherence between groups, using a multivariate analysis to measure the change between 
the comparison and control groups, improvement was calculated to demonstrate a p value of .05 
at a significance level of .05. Additionally, the qualitative evaluation reported repeating themes 
of improved adherence. One caregiver was quoted saying:  
“I’m very happy because he didn’t want to take his medication and now 
[after coming to VUKA Family Program] he takes it on time, with no 
difficulties. I think it’s also because he can see other children, he can see 
that he’s not the only one, there are many others…” [Caregiver response 
from Bhana et al. focus group][36] 
Based on these findings, it can be concluded that elements of the VUKA Family Program yielded 
improved self-reported rates of adherence in HIV-positive adolescents living in KwaZulu-Natal. 
3.2.2.2 Associations Between HIV-Disclosure and Adherence to Antiretroviral Treatment 
[28] 
Cluver et al. [28] conducted a cross-sectional study to measure the association between HIV-
status disclosure and ART adherence amongst adolescents in South Africa’s Eastern Cape 
Province. The study included 684 adolescents aged 10-19 years who were already in an ART 
program. An adolescent is considered to be disclosed to if they have been informed that they are 
HIV-positive and have an understanding of HIV and ART [48, 49]. Structured interviews and 
focus groups were used for the qualitative and quantitative measurements. Adherence was 
measured using self-reported measures that were adapted from a similar study conducted in 
Botswana [50], as well through the Patient Medication Adherence Questionnaire [51]. The 
results suggested that adolescent knowledge of HIV-positive status is associated with higher 
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adherence (OR 2.18; 95% CI 1.47-3.24), and there is an even stronger correlation between 
adherence levels and being disclosed to before the age of 12 (OR 2.65; 95% CI 1.34-5.22). Based 
on the results of this study, there is reason to believe that a relationship exists between adherence 
to ART and disclosure status for HIV-positive adolescents in the Eastern Cape. 
3.3 DISCUSSION 
The following discussion brings context to the findings identified above by placing them within 
the context of current literature. It aims to bring to light how the themes and concepts discovered 
do play an important role in ART adherence efforts for adolescents 
  
3.3.1 Health Care 
Perceptions of health care and quality of care provided can alter adherence efforts for HIV-
positive patients. Roberts [52] conducted a study in the United States to determine if there was a 
correlation between adult HIV-positive patients, satisfaction with their physician, and ART 
adherence. Results showed an apparent association between the perceived relationship and levels 
of adherence—good patient-provider relationships strengthened adherence and poor relationships 
hurt adherence. In fact, the literature demonstrates that there are specific factors within the 
patient-provider relationship that can affect adherence [53]. These factors include the patient-
professional relationship [54, 55], communication, and characteristics of the health professional 
(i.e. experiences with ARV treatment, attitudes towards the client [56]). Additionally, the 
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literature shows that the same holds true for adolescent patients [57]. When a positive patient-
provider relationship is present, there is a greater likelihood for information to be conveyed 
accurately and received completely. Conversely, poor patient-provider relationships can result in 
poor communication where the message is not accurately or clearly received, which may result 
in lower rates of patient compliance, adherence, and loss to follow up [58]. 
Pediatricians and adult physicians are often unprepared to identify and address the needs 
of their adolescent patients. Hence, there needs to be greater emphasis on adolescent-friendly 
health services. This includes facilities that are physically accessible, open at convenient times, 
require no appointment, offer free services, provide referrals for other needed services, and are 
staffed with clinicians who break down cultural, generational and gender-specific barriers [59].  
In efforts to properly address the emerging health concerns of the world’s adolescent population, 
UNICEF released the 2011 State of the World’s Children report [59], which identifies and 
addresses the unique challenges that adolescents pose in the health care setting. 
The results from this search demonstrate that patients value aspects of health care 
services such as relationships with providers, consistency, and open communication. These 
aspects of care are important to adolescents, and without taking them into consideration we 
cannot begin to address the issue of ART adherence.  
3.3.2 Mental Health 
Many HIV-positive individuals have experienced severe trauma and suffer from severe 
depression [60]. If an HIV-positive individual has a mental disorder, especially is the case for 
depression [61, 62] or have experienced trauma [63], they are less likely to have adequate ART 
adherence and more likely to experience treatment failure [64]. This is often is the case for HIV-
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positive adolescents, as many of them have lost one or both parents or primary caregivers. 
According to UNICEF [65], 2.5 million children lost one or both of their parents due to AIDS in 
2012. A study conducted by Rotheram-Borus et al. [66] found that adolescents in the United 
States bereaving the loss of a parent due to HIV-related causes had more emotional distress, 
more contact with the criminal justice system, increased reports of depressive symptoms, and 
increased instances of risky sexual behaviors when compared to non-bereaving adolescents of 
HIV-positive parents.  
The literature suggests that an individual’s ability to adhere to an ART regimen can be 
directly affected by their mental state. Additionally, as is the case with adolescents, HIV can 
negatively impact the mental health status of an individual. It therefore can be suggested that 
there is likely a correlation between the mental state of adolescents in South Africa and their 
ability to properly adhere to an ART regimen. 
3.3.3 Social Support 
Studies strongly suggest that there is a relationship between levels of social support and ART 
adherence among populations, such as, pregnant mothers in South Africa [67], newly diagnosed 
young adults in the United States [67], and adults in South Africa [68]. Social support has been 
identified to improve a patient’s mental health status and is known to help improve ART 
adherence [61, 69]. The themes uncovered from the literature search demonstrate that among 
HIV-positive adolescents in South Africa, social support may come by way of caregivers, 
friends, or clinicians.  Support may also come in the form of disclosing ones HIV-status to 
friends, family members or teachers. However, disclosing to friends or family can be a 
complicated process due to the high levels of HIV-related stigma and fear of potential shame [42, 
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43, 70]. When an adolescent is able to disclose their status to members within the community, 
there tends to be greater sense of support felt by the patient [44] and a lessened perception of 
stigma [36].  This decreased perception of stigma is linked to improved measures of mental 
health and adherence [71].  Additionally, patient support groups can aid in decreasing felt shame 
and stigma [72]. 
3.3.4 Disclosure 
Disclosure of HIV status is seen to have a positive correlation with adherence—as was observed 
in Cluver et al. [28], reported by the WHO [70], and found in a similar study conducted in 
Uganda [73].  Disclosure is of extreme importance and has implications for long-term ART 
adherence. It is not only important for the patient to know the name of the condition they have 
(HIV), but it is also important for them to have an understanding of HIV and ART [28]. In 
response to the data demonstrating the connection between disclosure and ART adherence, the 
WHO has created a recommended process for the disclosure of HIV-positive children [70]. This 
process takes into consideration the sensitive, and at times traumatic, nature of the disclosure 
process and has created recommendations to make it as effective as possible. 
3.4 STRENGTHS AND LIMITATIONS 
There are several limitations from this literature search worth noting. There were only two 
readers for the initial phases of the literature search, which could have introduced certain 
selection biases. Additionally, based on the guidance of the Health Systems Librarian, only three 
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databases were used to gather data, which may have excluded relevant papers published 
elsewhere. Lastly, the thematic review was solely based on the discretion of one reader, which 
may have allowed for inclusion and exclusion bias.  
The strengths of this literature review should be mentioned. The extensive assistance 
from a qualified librarian ensured that the search terms were formulated to extract the most 
relevant papers. The exclusion phase did rely on two independent readers that were strict with 
their inclusion criteria and also discussed papers that were disagreed upon. Any papers that were 
continually disagreed upon or were unclear as to whether they met the criteria, were kept and 
read by each reader.  
3.5 RECOMMENDATIONS 
The lack of relevant literature clearly demonstrates the need for more data in order to better 
understand the barriers that HIV-positive adolescents in South Africa face. Despite the lack of 
literature, there remains important themes and concepts that provide insight into the struggles of 
HIV-positive adolescents in care. I suggest that the data uncovered from this literature search be 
used to serve as the formative framework for the creation of a pilot program. 
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4.0  PROGRAM PLAN 
4.1 INTRODUCTION 
Findings from the literature search suggest that there is a range of barriers that hinder South 
African adolescents’ ability to fully adhere to an antiretroviral therapy (ART) regimen. This 
proposal outlines the development and pilot testing of a program that aims to further identify the 
barriers adolescents in this setting face, as well as to actively address these barriers by ways of 
video-making activities. The three aims of the project are as follows:  
Aim 1: Identify the top three barriers to ART adherence that HIV-positive adolescents 
self-report 
Aim 2: Create a pilot program that addresses the identified barriers  
Aim 3: Pilot test the program to identify if the adolescents involved were seen to have 
improved ART adherence, and whether this pilot can be scaled up to reach other similar 
communities 
The program will be conducted under the umbrella of Doctors Without Borders (MSF) pediatric 
and adolescent treatment failure clinic [37].  This pilot uses a multi-faceted approach to improve 
self-efficacy, knowledge and social-support for HIV-positive adolescents on antiretroviral 
therapy in Khayelitsha, a large township outside of Cape Town, South Africa. Increased ART 
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adherence will result from the creation and implementation of a video series for adolescents who 
are currently enrolled and receiving treatment at the treatment failure clinic. 
4.2 CONTEXT 
The national HIV prevalence rate in South Africa is 18.8% [3]. Additionally, the national 
prevalence rate for people aged 15 – 24 is 7.1% [3]. The Western Cape Province is known to 
have the lowest prevalence rate in South Africa, at 16.9% [74], and of those who are infected in 
the Western Cape, 44.1% of them are under the age of 24 [74]. While the Western Cape does 
have the lowest prevalence rate, there appears to be a large area where there is an apparent need 
for intervention.  
Khayelitsha, a township community located about 20 kilometers outside of the 
metropolitan center of Cape Town, is home to more than 400,000 people [75] and has an HIV 
prevalence rate of 33.1% [76].  Khayelitsha is a mixture of both formal and informal 
settlements—55% of the population lives in what is considered to be an informal settlement or 
dwelling [77]. An informal settlement, as defined by the South African Census is, “an unplanned 
settlement on land which has been surveyed or proclaimed as residential, consisting mainly of 
informal dwellings (shacks).” The definition for an informal dwelling is, “a makeshift structure 
not erected according to approved architectural plans”[78]. Only 62% of households in 
Khayelitsha have access to piped water in their home or yard, and 74% of households have a 
monthly income of 3,200 South African Rand or less (equivalent to about $238USD) [77]. 
Within the community, 99% of people are defined as black South African, and the majority of 
the population is under the age of 30. Additionally, only 36% of people living in Khayelitsha 20 
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years or older have completed grade 12 or higher [77]. Khayelitsha is a community of migrants – 
72% of the adult population above the age of 20 were born in the Eastern Cape Province [77, 
79], many of whom migrated for economic purposes [80].  
Khayelitsha is known to have very high rates of violence, which greatly affects the 
residents. Violence in this area is cited to be a constraint to self-employment, is a source of 
anxiety, and inhibits people from moving around at night [79]. Two of three young adults in 
Khayelitsha report having seen someone being hurt in their community, one in nine reported 
being the victim of a physical assault, and one in eight reported being a victim of armed robbery 
[79]. 
4.3 TARGET POPULATION 
The target population for this intervention is HIV-positive adolescents (10-19 years old) 
currently attending MSF’s treatment failure clinic in Khayelitsha. The clinic has two general 
groups of patients: 1) those who have an unsuppressed viral load, are failing treatment, and are 
currently seeking clinical care; and 2) those who are virologically suppressed and are enrolled in 
a family or teen support club [37, 81]. There are 144 HIV-positive pediatric patients enrolled in 
MSF’s treatment failure clinic [81]. While the data is unavailable about the stratification of ages 
within this group, based on MSF’s findings, it is known that 42% of the patient population falls 
within the age range 10-15 [37]. If remaining ages are equally distributed, this means that there 
are about 87 adolescent patients in the clinic. No data is available for the exact number of 
adolescent patients that are suppressed and have been transferred to a teen or family support 
club, but based on a report from MSF [81], it can be inferred that about 35 suppressed patients 
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are enrolled in a teen support club. Therefore, for the purposes of this pilot program plan, the 
target population consists of 35 suppressed adolescents enrolled in a support club and 52 non-
suppressed adolescents currently seeking care. While we do fully recognize that this is a 
convenience sample—and given the relationship that we have with MSF and the relationship that 
MSF has with the target population—it is reasonable to best determine the future impact of this 
program we pilot this program with a readily accessible population. 
4.4 PROGRAM APPROACH 
In order to best engage the adolescent community, we will employ a stakeholder-engaged 
approach and call upon the support and relationships that many of the adolescents have with the 
MSF clinic staff. We will work closely with staff to gain entrée with patients and caregivers of 
this community in order to build their trust so that they are more likely and willing to participate 
in the pilot program. 
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Figure 4. Pilot Program Logic Model 
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4.4.1 Aim 1: Identify the top three barriers to ART adherence that HIV-positive 
adolescents self-report 
Considering the lack of data available identifying the barriers that HIV-positive adolescents in 
South Africa face, and accounting for the unique context that a setting such as Khayelitsha 
presents, the first aim of the pilot program is to identify barriers that are most relevant for the 
adolescents living in this community. This will be accomplished by way of focus groups: three 
focus groups will be conducted with 5-7 adolescents from the support clubs. The aim of the 
focus groups is to facilitate an environment where adolescents can talk candidly about the 
barriers they faced before they were fully adherent to their ART regimen and what helped them 
to overcome said barriers. All of the focus groups will be audio recorded and then coded and 
analyzed in the ATLAS.ti software system. The results will be analyzed to determine the top 
three barriers identified by the adolescents; these three barriers will then be the themes for the 
movies that will be created. 
4.4.2 Aim 2: Create a pilot program that addresses the three identified barriers 
A new club, called the Ithemba Club (Xhosa for hope), will be established for adolescents from 
MSF’s treatment failure clinic who have achieved suppression and no longer need to seek regular 
care. The primary function of the Ithemba Club is to create three short films to be shown in the 
clinic to those who are currently not suppressed to aid in their adherence efforts. The filmmaking 
process will occur in the once-weekly club meetings, held in the clinics meeting rooms, under 
the supervision of the program’s Creative Director. The club members will be asked to work 
29 
together to create a script for the each of the films, with the goal of addressing how the identified 
barriers manifest themselves in their own lives and some practical problem solving skills that can 
be used to overcome these barriers.  The club members will also be responsible for recording and 
editing the film. The videos will be shown to the patients during their regular clinic 
appointments. This activity has three aims: 
• Aim 2a: Provide the non-suppressed adolescents with a tool that can help them to 
identify and address barriers that are interfering with their adherence efforts. The 
ability to identify barriers and solutions is in line with the evidence based 
intervention, Managed Problem Solving (MAPS), which is known to help HIV-
positive adults achieve higher rates of adherence and maintain an undetectable viral 
load [82]. We believe that a video is a good platform for this pilot because a previous 
study, conducted with HIV-positive adults in Soweto, South Africa [83], 
demonstrated that after viewing HIV management related videos patients were more 
likely to have improved understanding and knowledge of HIV and ART, which is a 
key factor for adequate adherence to be achieved. A different program, that used a 
story line based intervention with a relatable main character, demonstrated that an 
intervention using a multimedia approach could help improve adherence, treatment 
knowledge, and parent-child communication ability for HIV-positive adolescents in 
South Africa [36].  
• Aim 2b: Provide the non-suppressed adolescents with a vision of their community, 
and provide peer-support by presenting other people their age experiencing similar 
difficult situations. Peer Support is recognized by the CDC as an evidence-based 
intervention and best practice for HIV prevention [82]. A study in Paris, France 
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measured significant improvement in HIV-positive adolescent ART adherence, 
decreased negative perceptions of treatment as well as a higher number of patients 
with an undetectable viral load after being a member of a peer-support group [84].  
• Aim 2c: Encourage suppressed adolescents to fight medication fatigue and help them 
to continue adhering to their medication by providing them with a platform to discuss 
the difficulties they face, ideas on how to counteract difficulties, and training them to 
play a peer-supporter role to non-suppressed adolescents. Research shows that a peer-
support approach can not only provide support for the patient, but also for the 
supporter, as shown in studies with chronically ill patients [85]. Within the realm of 
HIV, a qualitative investigation was conducted to identify the impact that peer-
support has on the supporters. The findings suggested that being a peer-supporter 
created a greater sense of social acceptance, reciprocal support, as well as greater 
personal growth and empowerment [86].  
4.4.3 Aim 3: Pilot test the program to determine the program’s impact on adherence 
In efforts to determine whether this pilot program would be a feasible intervention in helping 
improve the adherence efforts for HIV-positive adolescents in South Africa, as well as to 
determine the scalability of this approach, four different data collection tools that will be used: 
1. Baseline questionnaire 
2. Follow-up questionnaire  
3. Biologic data  
4. Participant questionnaire 
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Baseline and Follow-Up Questionnaires 
These two questionnaires will be conducted at the onset and throughout the implementation of 
the pilot. The primary objective of this pilot is to determine ART adherence for adolescents who 
currently, or have previously, sought care from MSF’s treatment failure clinic; and to determine 
how participation in the pilot affects levels of adherence. This study has two sides to it – we wish 
to examine how active participation (i.e. assisting in the movie creation) in the pilot affects 
adherence, as well as how being a “consumer” (i.e. patients in the clinic who watch the movie) of 
the project affects adherence.  
Data will then be gathered to identify how the project negatively or positively affects the 
following: 1) Perception of care 2) Mental health 3) Measures of support 4) Caregiver support 5) 
Treatment knowledge 6) Perceived stigma. The following are the data collection objectives for 
the project accompanied by their validated measures. 
 
Study Objective Validated Measurement Used2 
Level of ART 
Adherence 
Pediatric AID Clinical Trials 
Group[87] 
Perception of Care Attitudes toward HIV Health Care Provider scale (AHHCP) [88] 
Youth Mental Health Strengths and Difficulties Questionnaire[89] 
Measures of Social 
Support Social Support Survey[90] 
Caregiver Support Family Support Scale [91] 
Youth HIV Treatment 
Knowledge HIV Treatment Knowledge Scale[92] 
Perceived Stigma HIV Stigma Scale[93] 
 Figure 5. Validated Evaluation Measures 
 
                                                 
2 Adapted from Bhana et al. [5] 
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Biologic Data 
The biologic data consists of the results from bloods tests that measure a patients’ viral load and 
CD4 count. Based on the South African guidelines [94], adolescents who are not suppressed are 
recommended to send their blood for testing every two months, and adolescents who are 
suppressed are recommended to send their blood in for testing every six months. In order to best 
compare the groups (those receiving the intervention vs. those not) we have decided to take the 
blood test of those involved in the pilot once every two months. The results from the tests are put 
into the patients’ medical chart and will be retrieved on a monthly basis by the Project Assistant. 
Collecting the biologic data is an important component to determine the biological impact that 
this program is having on the participants as well as to assess the validity of the self-reported 
adherence questionnaire.  
 
Participant Assessment  
The aim of this questionnaire is to ensure that the pilot is catering well to the target population, 
as to give us an idea if this is a program that can be scaled to reach other communities. This 
assessment will be conducted on two levels: firstly, for those who participated in the movie-
making project, and secondly, for those in the clinics who are watching the movies.  
The following are sample questions participants will be asked: 
• To the movie-making participants: 
o What did you enjoy about making the movie? 
o What didn’t you enjoy about making the movie? 
o Do you think that the topics addressed in the movies were relevant to patients in 
the clinic? 
o What issues, if any, do you wish the movies addressed? 
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• To the in-clinic patients watching the movie:
o Were the movies relevant to your life?
o Did you learn any good problem-solving skills from the movie? If so, what?
o Are there topics that you wish were covered in the movies?
o Were there any changes you would make to the movies to make them better?
4.4.4 Timeline 
Month Activities 
1-5 
• Project Manager creates and tests evaluation material (i.e. baseline and follow-
up questionnaire, virological reporting sheet)
• Project manager hires and trains assisting personnel (Project Assistant, Creative
Director, Data Analyst)
• Nurses are trained on administering data collection tools - including
questionnaire and biologic chart data
• Conduct three focus groups, analyze data and determine top three barriers to
adherence identified
• Collect baseline data
• Begin activities of the Ithemba Club –adolescents meet once a week to create
(write, product, edit, etc.) short films addressing barriers to adherence
6-18 
• Complete three short-films
• Begin showing films in clinic appointments
• Complete participant assessments for those who participated in making the
films
19-36 
• Continue to screen movie series in clinic appointments
• Complete midpoint evaluation
• Complete participant assessment for those who viewed short films in the clinic
• Complete final evaluation
Figure 6. Pilot Program Timeline 
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4.4.5 Budget 
The following numbers were assessed using an estimation of the standard salaries for individuals 
working in similar positions living in South Africa3.  All numbers were converted from the South 
African Rand to the US Dollar (based on the exchange rate of 1USD = 13.94 Rand). 
 
Table 1. Pilot Program Budget 
Supplies Personnel Percent Full-Time Effort 
Total Costs 
(USD) 
- 
Project Manger 
Annual Salary: 
$21,600* 
25.43% FTE 
(Over 36 months) $16,480.38 
- 
 
Project Assistant 
Annual Salary: 
$18,000* 
3.99% FTE 
(Over 36 months) $2,154.81 
- 
Creative Director 
Annual Salary: 
$16,800* 
7.50% FTE 
(Over 12 months) $1,260.00 
- 
Data Analyst (1) 
Annual Salary: 
$24,000* 
1.68% FTE 
(Twice during project) $403.85 
Printer 
($500/printer) - - $500 
Paper for Printer (20 cases) 
($25/case) - - $500 
Ink for Printer (10) 
$90/case - - $900 
Laptops (2) 
$400/laptop - - $400 
Audio Recording Device (1) - - $30 
ATLAS.ti Software (1) - - $1,300 
Misc. Supplies 
Pens, pencils, envelopes, etc. - - $200 
Total Personnel Costs $20,299.04 
Total Supplies Costs  $3,830.00 
Total Costs  $24,129.04 
 
                                                 
3 Numbers determined based on information from www.mywage.co.za. Part of the Wage Indicator Foundation 
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4.4.6 Conclusion 
Based on prior research [36, 82-84] we fully believe this intervention has the ability to improve 
adherence levels for HIV-positive adolescents attending MSF’s treatment failure clinic in 
Khayelitsha, South Africa. This pilot will help us to determine if this approach is a feasible way 
to reach this population, improve adherence, and determine if this program can be scaled to reach 
other communities throughout the region. This pilot program fills a gap in the literature and is an 
innovated applied research approach. With this implementation of this pilot we will be able to 
better understand the daily struggles that HIV-positive adolescents face with regards to their 
adherence efforts all while addressing and aiming to overcome the identified barriers.  
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APPENDIX A: SEARCH STRATEGY FOR PUBMED, PSYCINFO AND GLOBAL 
HEALTH DATABASES 
Base Term Search Term 
 
Antiretroviral 
Therapy 
PubMed 
(“Anti-HIV Agents/therapeutic use”[Mesh]) OR (“Antiretroviral Therapy, Highly Active”[Mesh]) 
OR Antiretroviral therapy[tiab] OR HAART[tiab] OR ART[tiab] OR ARV[tiab] OR ARVs[tiab] 
OR "Anti-HIV Agent"[tiab] OR "Anti-HIV Agents"[tiab] OR "HIV treatment"[tiab] OR "HIV 
treatments"[tiab] OR Antiretroviral therapy[ot] OR HAART[ot] OR ART[ot] OR ARV[ot] OR 
ARVs[ot] OR "Anti-HIV Agent"[ot] OR "Anti-HIV Agents"[ot] OR "HIV treatment"[ot] OR 
"zidovudine"[MeSH Terms] OR Zidovudine[tiab] OR AZT[tiab] OR Zidovudine[ot] OR AZT[ot] 
 
PsycINFO 
(exp zidovudine/ or exp antiviral drugs/ or exp aids/ or exp hiv/ or Antiretroviral therapy.ti,ab,hw. 
or HAART.ti,ab,hw. or ART.ti,ab,hw. or ARV.ti,ab,hw. or ARVs.ti,ab,hw. or "Anti-HIV 
Agent".ti,ab,hw. or "Anti-HIV Agents".ti,ab,hw. or "HIV treatment".ti,ab,hw. or "HIV 
treatments".ti,ab. or Zidovudine.ti,ab,hw. or AZT.ti,ab,hw.) 
Global Health 
(exp zidovudine/ or exp aids/ or exp hiv/ or Antiretroviral therapy.ti,ab,hw. or HAART.ti,ab,hw. 
or ART.ti,ab,hw. or ARV.ti,ab,hw. or ARVs.ti,ab,hw. or "Anti-HIV Agent".ti,ab,hw. or "Anti-
HIV Agents".ti,ab,hw. or "HIV treatment".ti,ab,hw. or "HIV treatments".ti,ab,hw. or 
Zidovudine.ti,ab,hw. or AZT.ti,ab,hw. or exp antiviral agents/ or exp treatment/ or exp 
antiretroviral agents or exp highly active antiretroviral therapy/ or exp multiple drug therapy/ or 
exp combination therapy/ or exp proteinase inhibitors/ or exp medical treatment) 
 
Medication 
Adherence 
PubMed 
(Medication adherence[Mesh] OR patient compliance [Mesh] OR patient acceptance of health 
care[Mesh]) OR (medication adherence[ot] OR medication nonadherence[ot] OR medication 
noncompliance[ot] OR medication non-compliance[ot] OR patient compliance[ot] OR treatment 
refusal[ot] OR patient acceptance of health care[ot] OR medication compliance[ot] OR 
retention[ot] OR loss to follow up[ot] OR “adolescent adherence” OR (medication 
adherence[tiab]) OR (adherence[All Fields] AND medication[tiab]) OR adherence OR medication 
nonadherence[tiab] OR medication noncompliance[tiab] OR medication non-compliance[tiab] OR 
patient compliance[tiab] OR treatment refusal[tiab] OR patient acceptance of health care[tiab] OR 
treatment failure OR medication compliance[tiab] OR retention[tiab] OR loss to follow up[tiab] 
 
PsycINFO 
(exp treatment compliance/ or exp intervention/ or exp client attitudes/ or patients.mp. or 
medication adherence.hw,ti,ab. or medication nonadherence.hw,ti,ab. or medication 
noncompliance.hw,ti,ab. or medication non-compliance.hw,ti,ab. or patient compliance.hw,ti,ab. 
or treatment refusal.hw,ti,ab. or patient acceptance of health care.hw,ti,ab. or medication 
compliance.hw,ti,ab. or retention.hw,ti,ab. or loss to follow up.hw,ti,ab. or "adolescent 
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adherence".af. or (adherence.af. and medication.ti,ab.) or adherence.af. or exp treatment 
outcomes/ or ("treatment" and "failure").af. or "treatment failure".af.) 
 
Global Health 
(exp intervention/ or patients.mp. or medication adherence.hw,ti,ab. or medication 
nonadherence.hw,ti,ab. or medication noncompliance.hw,ti,ab. or medication non-
compliance.hw,ti,ab. or patient compliance.hw,ti,ab. or treatment refusal.hw,ti,ab. or patient 
acceptance of health care.hw,ti,ab. or medication compliance.hw,ti,ab. or retention.hw,ti,ab. or 
loss to follow up.hw,ti,ab. or "adolescent adherence".af. or (adherence.af. and medication.ti,ab.) or 
adherence.af. or ("treatment" and "failure").af. or "treatment failure".af. OR exp patient 
compliance) 
 
HIV/AIDS 
PubMed 
(HIV[tiab] OR HIV[ot]) OR (HIV/AIDS) OR (AIDS[mesh] OR AIDS[tiab] OR AIDS[ot]) OR 
(human immunodeficiency virus[mesh] OR human immunodeficiency virus[tiab] OR human 
immunodeficiency virus[ot]) OR (acquired immunodeficiency syndrome[tiab] OR acquired 
immunodeficiency syndrome[ot]) OR (HIV-2[tiab] OR HIV- 2[ot]) OR (HIV-1[tiab] OR HIV-
1[ot]) OR (HIV infections [Mesh]) 
 
PsycINFO 
(HIV.hw,ti,ab. or exp HIV/ or AIDS.ti,ab,hw. or human immunodeficiency virus.ti,ab,hw. or 
acquired immunodeficiency syndrome.ti,ab,hw. or HIV-2.ti,ab,hw. or HIV-1.ti,ab,hw.) 
 
Global Health 
(HIV.ti,ab,hw. or exp HIV/ or AIDS.ti,ab,hw. or human immunodeficiency virus.ti,ab,hw. or 
acquired immunodeficiency syndrome.ti,ab,hw. or HIV-2.ti,ab,hw. or HIV-1.ti,ab,hw.) 
 
Adolescent 
PubMed 
(youth[ot] OR youth[tiab] OR youths[ot] OR youths[tiab]) OR (teen[ot] OR teen[tiab] OR 
teens[ot] OR teens[tiab]) OR (adolescent[tiab] OR adolescent[ot] OR "adolescent"[MeSH Terms] 
OR adolescents[tiab] OR adolescents[ot] 
 
PsycINFO 
(exp adolescent attitudes/ or adolescent.mp. or youth.ti,ab,hw. or youths.hw,ti,ab. or teen.hw,ti,ab. 
or teens.hw,ti,ab. or adolescent.ti,ab,hw. or adolescents.ti,ab,hw.) 
 
Global Health 
(exp adolescents/ or adolescent.mp. or youth.hw,ti,ab. or youths.hw,ti,ab. or teen.hw,ti,ab. or 
teens.hw,ti,ab. or adolescent.hw,ti,ab. or adolescents.hw,ti,ab.) 
 
South Africa 
PubMed 
South Africa[tiab] OR South Africa[ot] 
 
PsycINFO 
"South Africa".mp. 
 
Global Health 
"South Africa".mp. 
 
. 
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APPENDIX B: EXAMPLE INITIAL SORTING GUIDE - PSYCINFO 
Keep/Pass Pass – Reasoning Article Info (n=47) Abstract 
 
[Readers fill in 
their decision 
following 
reading the 
article 
information 
and abstract] 
 
[If readers decide 
to pass, they 
present their 
reaoning] 
 
Amirfar, S., et al. (2006). 
"Modeling the Impact of a 
Partially Effective HIV 
Vaccine on HIV Infection 
and Death Among Women 
and Infants in South Africa." 
JAIDS Journal of Acquired 
Immune Deficiency 
Syndromes 43(2): 219-225. 
 
Objective: To assess the potential impact over 10 
years of a partially effective HIV vaccine in a 
cohort of 15-year-old adolescent girls in South 
Africa in terms of HIV infections and deaths 
prevented in mothers and infants. Methods: A 
computer simulation was constructed using a 
population of all 15-year-old adolescent girls in 
South Africa followed for 10 years… 
 
   
Armistead, L., et al. (2014). 
"Preliminary results from a 
family-based HIV 
prevention intervention for 
South African youth." 
Health Psychology 33(7): 
668-676. 
Objectives: Approximately 5.6 million South 
Africans are living with human immunodeficiency 
virus (HIV; UNAIDS, 2010). Prevalence among 
Black adolescents and young adults is particularly 
alarming. This pilot study of an HIV preventive 
intervention targeting South African youth 
contributes to the growing body of research on 
culturally competent family-based interventions. 
Method: A total of 99 parent-child dyads were 
enrolled in an experimental repeated measures 
study, using a wait-list control group… 
 
   
Balfour, L., et al. (2013). 
"HIV prevention in action 
on the football field: The 
Whizzkids United program 
in South Africa." AIDS and 
Behavior 17(6): 2045-2052. 
 
The Africaid Trust is a grassroots South African 
non-profit organization that engages youth in HIV 
prevention by harnessing the popularity of football 
(i.e. soccer). WhizzKids United, the organization's 
primary program, operates a 12-week program in 
elementary schools in Pietermaritzburg, South 
Africa, which aims to impart knowledge and life 
skills critical to HIV prevention. The goal of this 
research was to compare elementary school youth 
who received the program to youth who … 
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